1 / 37

Global Vaccine Introduction and Implementation IVAC VIEW-hub Report

This report provides historical data on the introduction and implementation of various vaccines globally, including PCV, Rotavirus, IPV, and Hib vaccines, categorized by income group. It also includes information on current product coverage and dosing schedules in Gavi countries.

amccoy
Download Presentation

Global Vaccine Introduction and Implementation IVAC VIEW-hub Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. VIEW-hub Report: Global Vaccine Introduction and Implementation IVAC VIEW-hub Global Vaccine Introduction and Implementation Report March 2019 Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center (IVAC) Developed from information in the VIEW-hub database/platform For other VIEW-hub-related inquiries, please contact Kirthini Muralidharan at kmurali2@jhu.edu

  2. Historical PCV vs. Rotavirus Vaccine Introduction, by Income Group Note: Limited projections are available for high income countries. Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  3. Historical PCV Introduction by Income Group Note: Limited projections are available for high, upper-middle, and lower-middle income countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  4. Historical Rotavirus Vaccine Introduction by Income Group Note: Limited projections are available for high, upper-middle, and lower-middle income countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  5. Historical IPV Introduction by Income Group Note: Limited projections are available for high, upper-middle, and lower-middle income countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  6. Global Introduction Status of Hib Vaccine Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  7. Global PCV Introduction Status by Year Target: 194 countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  8. Global PCV Introduction Status Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  9. Global Introduction Status of PCV Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  10. PCV – Current Product Gavi countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  11. PCV – Current Dosing Schedule Gavi countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  12. Global Coverage and Access to PCV Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  13. Gavi PCV Introduction Status by Year Target: 73 countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  14. Gavi PCV Introduction Status Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  15. Gavi Countries’ Introduction Status of PCV Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  16. Coverage and Access to PCV in Gavi Countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  17. Global Rotavirus Vaccine Introduction Status by Year Target: 194 countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  18. Global Rotavirus Vaccine Introduction Status Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  19. Global Introduction Status of Rotavirus Vaccine Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  20. Rotavirus Vaccine – Current Product Gavi countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  21. Rotavirus Vaccine – Current Dosing Schedule Gavi countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  22. Global Coverage and Access to Rotavirus Vaccine Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  23. Gavi Rotavirus Vaccine Introduction Status by Year Target: 73 countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  24. Gavi Rotavirus Vaccine Introduction Status Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  25. Gavi Countries’ Introduction Status of Rotavirus Vaccine Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  26. Coverage and Access to Rotavirus Vaccine in Gavi Countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  27. Global IPV Introduction Status by Year Target: 194 countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  28. Global IPV Introduction Status Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  29. Global Introduction Status of IPV Countries using IPV without OPV (50) Note: All other IPV-using countries are also using OPV in their national schedule. Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  30. IPV – Current Product Gavi countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  31. IPV– Current Dosing Schedule Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  32. Global Coverage and Access to IPV Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  33. Gavi IPV Introduction Status by Year Target: 73 countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  34. Gavi IPV Introduction Status Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  35. Gavi Countries’ Introduction Status of IPV Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  36. Coverage and Access to IPV in Gavi Countries Source: International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub Global Vaccine Introduction and Implementation Report, March 2019.

  37. Acknowledgements and Notes This report is developed by the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, with support from Gavi, the Bill & Melinda Gates Foundation, The Task Force for Global Health and ROTA Council. Please note that all forecasted introductions in this report rest on assumptions and may vary. Planned vaccine introduction dates do not imply an obligation by Gavi to support coverage. Definitions and sources are available in VIEW-hub at www.VIEW-hub.org. The most current VIEW-hub Report and matching slides can be found at: http://ivac.jhu.edu/resources/view-hub-reports/. For any VIEW-hub-related inquiries, please email Kirthini Muralidharan at kmurali2@jhu.edu.

More Related